Login

Register

Become a member of The Cuenca Dispatch and access exclusive weekly reports on Ecuador's economy, politics, crime and more that you will not find published anywhere else on the web.

Ecuador's Original English Language Newspaper

The first ‘authorized’ drug against Covid-19 costs thousands in Ecuador

Published on June 08, 2021
Facebook Twitter Google+ LinkedIn Although remdesivir does not have a sanitary registration in Ecuador, and its use has not yet been officially approved, there are doctors who are prescribing it. Andrea’s 50-year-old father is in the intensive care unit at a Guayaquil hospital because he was infected with Covid-19. She says that to “improve” his condition, […]

To view this article you must have an active subscription.

Already a member? Sign in.

Subscribe to weekly reports on Ecuador’s economics, politics, crime and more.

Not sure you want to commit? Don’t worry, you can cancel anytime.

For a limited time,
subscribe now and get your first month for only $1.

Regular subscriptions available at $4.99/month or $42/year.

0 Comments

More from this issue

Donuts aren’t the only things with holes in them

This week I want to talk about something completely unrelated to politics or the coronavirus, and that’s work ethic. Right now, we have two local brothers, both in their mid-twenties, working on construction projects at our house. We’ve had them there for 3 months. We started first with having them rebuild an old carport that […] To view this article you must have an active subscription. Already a member? Sign in. Subscribe to weekly reports on Ecuador’s economics, politics, crime and more. Not sure you want to commit? Don’t worry, you can cancel anytime. For a limited time,subscribe now and get your first month for only $1. Regular subscriptions available at $4.99/month or $42/year. Subscribe now!

Numbers Of Deaths And Hospitalizations Fall Again, New Vaccination Plan Rolled Out With Promises Of More Vaccines

We are two weeks out from the lifting of restrictions and the number of new cases and new deaths continue to fall. In the past, we have seen a rise in these numbers at around 2-3 week’s post increases in mobility. So, it is encouraging to see these numbers continue to improve even as we […] To view this article you must have an active subscription. Already a member? Sign in. Subscribe to weekly reports on Ecuador’s economics, politics, crime and more. Not sure you want to commit? Don’t worry, you can cancel anytime. For a limited time,subscribe now and get your first month for only $1. Regular subscriptions available at $4.99/month or $42/year. Subscribe now!

Update 06-06-2021

Update to: Quito mayor on trial for embezzlement; Ombudsman arrested for sexual assault Published: Volume 5, Issue32 The Municipal Council removed Jorge Yunda from the position of mayor of Quito It took the Metropolitan Council of Quito more than eight hours last week to decide the removal of Jorge Yunda as Mayor of Quito, in […] To view this article you must have an active subscription. Already a member? Sign in. Subscribe to weekly reports on Ecuador’s economics, politics, crime and more. Not sure you want to commit? Don’t worry, you can cancel anytime. For a limited time,subscribe now and get your first month for only $1. Regular subscriptions available at $4.99/month or $42/year. Subscribe now!

Sinovac vaccine restores a Brazilian city to near normal

Just one COVID-19 patient is in critical condition at the Dr. Geraldo Cesar Reis clinic in Serrana, a city of almost 46,000 in Sao Paulo state’s countryside. The 63-year-old woman rejected the vaccine that was offered to every adult resident of Serrana as part of a trial. Doctors say the woman was awaiting one of […] To view this article you must have an active subscription. Already a member? Sign in. Subscribe to weekly reports on Ecuador’s economics, politics, crime and more. Not sure you want to commit? Don’t worry, you can cancel anytime. For a limited time,subscribe now and get your first month for only $1. Regular subscriptions available at $4.99/month or $42/year. Subscribe now!
Share This